Zydus Cadila is a fully integrated, global healthcare provider, with strengths all along the pharmaceutical value chain. With a core competence in the field of healthcare, Zydus Cadila provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients and animal healthcare products to wellness products. Zydus is the only Indian pharma company to launch its own patented NCE - Lipaglyn, the world's first drug to be approved for the treatment of diabetic dyslipidemia.
Zydus Cadila: Dedicated to life
|2014||Mr Pankaj R Patel, Chairman and MD, Zydus Cadila was conferred the India Innovator Award 2013|
|2013||Zydus pioneers a breakthrough with Lipaglyn, India's first NCE to reach the market|
|2007||Zydus Cadila, the first to launch revolutionary anti-obesity drug Slimona in India|
|1995||Posted a turnover of Rs 250 crore (US$ 40.52 million)|
|1952||Zydus Cadila started opertaion|
Updated: November, 2014